XWEL
XWELL, Inc. NASDAQ Listed Jul 27, 2010$1.04
+0.97%
vs $1.03
Mkt Cap $5.8M
52w Low $0.29
53.3% of range
52w High $1.70
50d MA $1.26
200d MA $0.97
P/E (TTM)
-0.2x
EV/EBITDA
—
P/B
—
Debt/Equity
-0.6x
ROE
76.3%
P/FCF
-0.5x
RSI (14)
33.30
ATR (14)
$0.08
Beta
0.96
50d MA
$1.26
200d MA
$0.97
Avg Volume
105.0K
XWELL Inc., a health and wellness services company, provides spa services at airports. It operates through XpresSpa, XpresTest, Treat, and HyperPointe brands. The company offers spa services, including massage, and nail and skin care, as well as spa and travel products; and retail products. It also operates wellness centers that provides COVID-19 screening and testing, and rapid testing services for other communicable diseases, such as influenza, COVID-19, RSV, Flu A&B, and seasonal flu vaccination services; and other medical diagnostic testing services. In addition, the company offers services through an integrated digital platform, and a relevant retail offering to the traveling public. As of December 31, 2021, it operated 52 spa and clinic locations in 24 airports in the United States, the Netherlands, and the United Arab Emirates. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL Inc. in October 2022. XWELL Inc. is headquartered in New York, New York.
254 West 31st Street · New York City, NY 10001 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | AMC | -1.00 | -3.29 | -229.0% | 1.16 | -1.7% | -7.8% | +42.1% | -15.1% | +1.6% | -6.1% | — |
| Nov 14, 2025 | AMC | — | -0.26 | — | 0.83 | -3.7% | +11.8% | -3.1% | -5.5% | -10.8% | -1.1% | — |
| Aug 14, 2025 | AMC | — | -0.56 | — | 1.20 | -1.7% | -5.8% | +3.5% | -4.3% | -1.8% | -1.8% | — |
| May 20, 2025 | AMC | — | -1.00 | — | 0.92 | -2.1% | -6.3% | +6.7% | -2.2% | -4.2% | +1.1% | — |
| Nov 14, 2024 | AMC | — | -0.99 | — | 1.68 | -1.8% | -1.8% | -5.5% | -2.6% | -2.0% | -2.7% | — |
| Aug 14, 2024 | AMC | — | -0.48 | — | 1.96 | -9.7% | +1.0% | -2.5% | -1.6% | +0.0% | -2.6% | — |
| Apr 29, 2024 | AMC | -0.82 | -1.58 | -92.1% | 1.76 | -0.6% | +1.1% | -3.9% | +3.5% | +1.1% | +0.6% | — |
| Apr 16, 2024 | AMC | -0.82 | -1.57 | -91.5% | 1.37 | +2.2% | +1.5% | +0.7% | -1.4% | -2.2% | +5.2% | — |
| Nov 14, 2023 | AMC | -0.80 | -0.76 | +5.0% | 1.71 | +5.3% | -4.1% | +12.8% | +17.8% | -6.9% | -1.5% | — |
| Aug 14, 2023 | AMC | -1.40 | -1.40 | +0.0% | 4.60 | -8.7% | -8.7% | +0.0% | +4.8% | +4.5% | +0.0% | — |
| Apr 17, 2023 | AMC | -0.13 | -3.00 | -2207.7% | 6.80 | +0.0% | -8.8% | +0.0% | +3.2% | -9.4% | -3.4% | — |
| Mar 21, 2023 | AMC | -0.05 | 0.03 | +160.0% | 7.20 | +5.6% | +0.0% | +2.8% | +0.0% | +0.0% | +0.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.85 | $1.95 | +5.4% | +17.8% | -6.9% | -1.5% | +0.0% | +3.0% |
| Aug 25 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.20 | $4.00 | -4.8% | +0.0% | -9.5% | +0.0% | -5.3% | +0.0% |
| Aug 24 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.40 | $4.40 | +0.0% | -4.5% | +0.0% | -9.5% | +0.0% | -5.3% |
| May 16 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.80 | $4.80 | +0.0% | +0.0% | +4.2% | +0.0% | +0.0% | +0.0% |
| May 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.80 | $4.80 | +0.0% | +0.0% | +0.0% | +4.2% | +0.0% | +0.0% |
| Apr 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.20 | $6.80 | +9.7% | +3.2% | -6.2% | +3.3% | -6.5% | +3.4% |
| Apr 3 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.20 | $7.00 | -2.8% | -13.9% | +3.2% | -6.2% | +3.3% | -6.5% |
| Nov 16 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $10.00 | $10.00 | +0.0% | -10.0% | -6.7% | +2.4% | -2.3% | -7.1% |
| Nov 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $10.40 | $10.40 | +0.0% | -3.8% | -10.0% | -6.7% | +2.4% | -2.3% |
| May 18 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $16.40 | $16.20 | -1.2% | -7.3% | +0.0% | -2.6% | -1.4% | -1.4% |
| May 17 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $18.00 | $16.80 | -6.7% | -8.9% | -7.3% | +0.0% | -2.6% | -1.4% |
| Nov 17 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $29.00 | $29.60 | +2.1% | +6.2% | -2.6% | +3.3% | -2.6% | -1.3% |
| Nov 16 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $30.60 | $29.60 | -3.3% | -5.2% | +6.2% | -2.6% | +3.3% | -2.6% |
No insider trades available.
NT 10-Q
!! High
XWELL, Inc. -- Late Quarterly Report -- Distress Signal
May 15
8-K
Unknown — 8-K Filing
I appreciate your interest, but the filing summary provided is incomplete and appears to contain only technical XBRL metadata rather than substantive business information. I cannot write a meaningful analyst sentence without actual disclosure content about XWEL's business developments, financial results, or material events.
Apr 10
NT 10-K
!!! Very High
Unknown — Late Annual Report — Distress Signal
XWEL's late annual report filing signals potential financial distress or operational issues, raising delisting risk and warranting immediate investor scrutiny of governance and liquidity concerns.
Apr 1
8-K
Unknown — 8-K Filing
I cannot provide a meaningful analysis as the filing excerpt contains only standard disclaimer language about forward-looking statements with no substantive business information disclosed.
Apr 1
8-K · 1.01
! Medium
XWELL, Inc. -- 8-K 1.01: Equity Issuance
XWELL Inc. entered into a Securities Purchase Agreement with Dominari Securities LLC, indicating the company is raising capital through equity issuance to strengthen its financial position.
Mar 4
8-K · 1.01
! Medium
XWELL, Inc. -- 8-K 1.01: Equity Issuance
XWELL agreed to issue equity worth $31.3 million to Dominari Securities LLC, potentially diluting existing shareholders but providing the company with capital for operations or growth.
Feb 25
Institutional (13F) — Top 7
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management Llc | 51,310 | $59K | New | Mar 2026 |
| 2 | Ubs Group Ag | 12,087 | $14K | Added | Mar 2026 |
| 3 | Ground Swell Capital, Llc | 10,206 | $5K | New | Dec 2025 |
| 4 | Citigroup Inc | 8,133 | $4K | Added | Dec 2025 |
| 5 | Morgan Stanley | 5,402 | $2K | Reduced | Dec 2025 |
| 6 | Activest Wealth Management | 50 | $23 | — | Dec 2025 |
| 7 | Royal Bank Of Canada | 1 | — | — | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 3
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | Fidelity Extended Market Index Fund | 29,749 | $44K | Feb 2026 |
| 2 | Fidelity Series Total Market Index Fund | 7,323 | $11K | Feb 2026 |
| 3 | Fidelity Total Market Index Fund | 6,204 | $9K | Feb 2026 |
Valuation
Market Cap
$5.8M
Enterprise Value
$3.2M
P/E (TTM)
-0.19x
Forward P/E
—
PEG Ratio
-0.00x
P/B
—
P/S
0.20x
P/FCF
-0.50x
EV/EBITDA
—
Shares Out
5.6M
Financials (TTM)
Revenue
$28.8M
Net Income
-$23.4M
EBITDA
-$21.3M
Free Cash Flow
-$11.7M
Op Cash Flow
-$8.7M
EPS Basic
$-5.08
EPS Diluted
$-5.59
EPS Forward
—
Gross Margin
26.0%
Op Margin
-40.3%
Net Margin
-81.3%
Balance Sheet
Total Assets
$11.2M
Total Liab.
$23.8M
Total Equity
-$12.6M
Cash
$2.6M
LT Debt
$0
Book Value/Sh
$-2.26
Debt/Equity
-0.57x
Current Ratio
0.46
Quick Ratio
0.42
Returns & Growth
ROE
76.3%
ROA
-151.5%
ROIC
-247.7%
Rev Growth YoY
-13.8%
EPS Growth YoY
-38.8%
Price Returns
2W
-14.8%
1M
-16.1%
3M
-10.3%
6M
+131.1%
12M
+13.0%
Technicals
52W High
$1.70
52W Low
$0.29
50d MA
$1.26
200d MA
$0.97
RSI (14)
33.30
ATR (14)
$0.08
Beta
0.96
Avg Volume
105K
Dividends
Div Rate
$0.05
Div Yield
3.8%
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
—
High
—
Low
—
Median
—
Data updated apr 27, 2026 10:58am
· Source: financialmodelingprep.com